Actively Recruiting
Improve Outcomes for Older Allogeneic Transplant Recipients
Led by Abramson Cancer Center at Penn Medicine · Updated on 2025-12-10
72
Participants Needed
1
Research Sites
432 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.
CONDITIONS
Official Title
Improve Outcomes for Older Allogeneic Transplant Recipients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older.
- Planned allogeneic hematopoietic cell transplantation (HCT) in the next 1 to 6 months for Cohort A (Prehab).
- Diagnosed with hematological malignancy as the reason for HCT.
- Classified as pre-frail or frail by Fried frailty phenotype for Cohort A (Prehab).
- Planned allogeneic HCT or HCT within the last 30 days for Cohort B (Rehab).
- Age 60 years or older for Cohort B (Rehab).
You will not qualify if you...
- Presence of comorbid disability or illness that prevents safe participation in exercise for both Cohorts A and B.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Penn Medicine
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
J
Jacqui Rick
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here